Back to Organizations
Genesis Molecular AI
AI-focused biotechnology company developing molecular-AI systems and small-molecule drug candidates for internal programs and pharmaceutical partners.
San Mateo, United States
Current Funding Stage
SeedCurrent recognized equity stage. The rounds below remain the historical funding record.
Funding Rounds
Funding Round: Equity investment
Funding Date: 13 Nov, 2024
Funding Round: Seed
Funding Date: 21 Nov, 2019
Raised Amount: $4.1M
Funding Round: Series B
Funding Date: Unknown
Raised Amount: $200M